InsiderCIK 2118509

Paul Glavine: Insider Trades

Every open-market purchase and sale Paul Glavine reported on Form 4 since Aug 13, 2026, with how the stock moved after each purchase.

HELP Helus Pharma Inc. · Chief Growth Officer

4Purchases

$4.72MBought

0Sales

$0Sold

Track record of purchases

Not enough time has passed, or price data is missing, to measure these purchases yet.

Change in the stock price from the price paid to the closest weekly price about 1, 3 and 6 months later, from SEC fails-to-deliver data. Dividends are not included, and purchases with a possible stock split in between are skipped. Past results do not predict future ones. How we measure this

All reported trades

Trades by Paul Glavine
Filed	Traded	Ticker	Role	Type	Shares	Price ($)	Value	Holding	Filing
Sep 11	Sep 8	HELP	Chief Growth Officer	▲ BUY	100,000	12.47	$1.25M	+2.4%	Form 4 ↗
Sep 11	Sep 8	HELP	Chief Growth Officer	▲ BUY	100,000	12.47	$1.25M	+2.4%	Form 4 ↗
Sep 10	Sep 3	HELP	Chief Growth Officer	▲ BUY	100,000	11.78	$1.18M	+2.5%	Form 4 ↗
Sep 9	Aug 31	HELP	Chief Growth Officer	▲ BUY	90,000	11.59	$1.04M	+2.3%	Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Names come from the filings. Different people can share a name, so we group trades by the SEC's reporting-owner number (CIK) instead.